AU2001281099A1 - Production of human monoclonal antibodies - Google Patents
Production of human monoclonal antibodiesInfo
- Publication number
- AU2001281099A1 AU2001281099A1 AU2001281099A AU8109901A AU2001281099A1 AU 2001281099 A1 AU2001281099 A1 AU 2001281099A1 AU 2001281099 A AU2001281099 A AU 2001281099A AU 8109901 A AU8109901 A AU 8109901A AU 2001281099 A1 AU2001281099 A1 AU 2001281099A1
- Authority
- AU
- Australia
- Prior art keywords
- production
- monoclonal antibodies
- human monoclonal
- human
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/166—Animal cells resulting from interspecies fusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22247300P | 2000-08-02 | 2000-08-02 | |
US60/222,473 | 2000-08-02 | ||
US09/759,984 | 2001-01-12 | ||
US09/759,984 US20020045219A1 (en) | 2000-08-02 | 2001-01-12 | Production of human monoclonal antibodies |
PCT/US2001/024591 WO2002010352A2 (en) | 2000-08-02 | 2001-08-01 | Production of human monoclonal antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001281099A1 true AU2001281099A1 (en) | 2002-02-13 |
Family
ID=26916832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001281099A Abandoned AU2001281099A1 (en) | 2000-08-02 | 2001-08-01 | Production of human monoclonal antibodies |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020045219A1 (en) |
AU (1) | AU2001281099A1 (en) |
WO (1) | WO2002010352A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002090570A2 (en) * | 2001-05-08 | 2002-11-14 | Sierra Sciences, Inc. | Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
AU2002357932A1 (en) * | 2001-12-18 | 2003-06-30 | Whitehead Institute For Biomedical Research | Fusion partner cells and uses thereof |
WO2006039400A2 (en) * | 2004-09-29 | 2006-04-13 | Mount Sinai School Of Medicine Of New York University | Fsh and fsh receptor modulator compositions and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639613A (en) * | 1992-05-13 | 1997-06-17 | Board Of Regents, University Of Texas System | Methods for cancer diagnosis and prognosis |
US5645986A (en) * | 1992-05-13 | 1997-07-08 | Board Of Reagents, The University Of Texas System | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
US5686306A (en) * | 1992-05-13 | 1997-11-11 | Board Of Regents, The University Of Texas System | Methods and reagents for lengthening telomeres |
US5989807A (en) * | 1992-05-13 | 1999-11-23 | Geron Corporation & Board Of Regents | Detecting cancerous conditions by assaying for telomerase activity |
US5648215A (en) * | 1992-05-13 | 1997-07-15 | Board Of Regents, The University Of Texas System | Telomerase diagnostic methods |
US5837453A (en) * | 1992-05-13 | 1998-11-17 | Geron Corporation | Telomerase activity assays |
US5693474A (en) * | 1992-05-13 | 1997-12-02 | Board Of Regents, University Of Texas System | Methods for cancer diagnosis and prognosis |
US5629154A (en) * | 1993-11-12 | 1997-05-13 | Geron Corporation | Telomerase activity assays |
WO1995013383A1 (en) * | 1993-11-12 | 1995-05-18 | Geron Corporation | Methods and reagents for lengthening telomeres |
US5804380A (en) * | 1993-11-12 | 1998-09-08 | Geron Corporation | Telomerase activity assays |
US5863726A (en) * | 1993-11-12 | 1999-01-26 | Geron Corporation | Telomerase activity assays |
IL137101A0 (en) * | 1998-01-12 | 2001-06-14 | Cold Spring Harbor Lab | Extension of cellular lifespan, methods and reagents |
-
2001
- 2001-01-12 US US09/759,984 patent/US20020045219A1/en not_active Abandoned
- 2001-08-01 WO PCT/US2001/024591 patent/WO2002010352A2/en active Application Filing
- 2001-08-01 AU AU2001281099A patent/AU2001281099A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002010352A3 (en) | 2003-02-27 |
US20020045219A1 (en) | 2002-04-18 |
WO2002010352A2 (en) | 2002-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL212419A0 (en) | Methods of administering anti-tnf antibodies | |
AU1462300A (en) | Human pan-hcv human monoclonal antibodies | |
AU2001294175A1 (en) | Method of purifying antibody | |
AU2001259215A1 (en) | Human anti-cd40 antibodies and methods of making and using same | |
AU2002256895A1 (en) | Anti-TRAIL-R antibodies | |
HUP0402164A3 (en) | Polycistronic expression of antibodies | |
EP1372718A4 (en) | Production and use of novel peptide-based agents for use with bi-specific antibodies | |
PL354112A1 (en) | Application of anti-ctla-4 antibodies | |
HK1061403A1 (en) | ANTIBODIES TO HUMAN IL-1ß | |
AU2001280201A1 (en) | Methods of synthesizing cell-free protein | |
AU2001256325A1 (en) | Human and humanized fap-alpha-specific antibodies | |
AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
AU2002365649A1 (en) | Anti-dota antibody | |
AU5441000A (en) | Human monoclonal antibody | |
AU2002251821A1 (en) | Nicotine immunogens and antibodies and uses thereof | |
AU2001265935A1 (en) | Production of biohydrolysates | |
AU2003260871A1 (en) | Hybridomas producing high levels of human sequence antibody | |
AU2003276844A1 (en) | Formulations of modified antibodies and methods of making the same | |
AU2001280368A1 (en) | Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy | |
AU2001281099A1 (en) | Production of human monoclonal antibodies | |
AU1735801A (en) | Antibody against human kgfr | |
AU2002221132A1 (en) | Novel antibody | |
AU2002242447A1 (en) | Use of polyclonal immunoglobulins | |
AUPQ743300A0 (en) | Separation of avian antibodies | |
AU2002210855A1 (en) | Synthesis of fused pyrrolecarboxamides |